$TNGX 3 SEC Filings

Filed On	Filing
23 Jun 2026	Form 3: Azelby Robert, Director No securities owned
24 Apr 2026	Form 3: Newcomb Jessica, Principal Accounting Officer Holds 67,321 shares of Common Stock
24 Apr 2026	Form 3: Gall Matthew, Chief Financial Officer No securities owned
06 Jan 2026	Form 3: Lee Sung, Director No securities owned
22 Oct 2024	Form 3: Boxer Capital Management, Llc, See remarks. Holds 8,198,642 shares of Common Stock
14 Nov 2023	Form 3: Pothula Kanishka, Director No securities owned
16 Oct 2023	Form 3: EcoR1 Capital, Llc, 10% owner Holds 13,330,736 shares of Common Stock
31 Aug 2023	Form 3: Ketchum John B, Director No securities owned
22 Aug 2023	Form 3: Third Rock Ventures VI, L.p., Director and 2 others Holds 194,174 shares of Common Stock
02 Mar 2023	Form 3: Crystal Adam, See Remarks No securities owned
05 Dec 2022	Form 3: Weitzman Aaron, Chief Medical Officer No securities owned
04 Jan 2022	Form 3: Braslyn Ltd., 10% owner and 1 other Holds 26,961 shares of Common Stock
10 Dec 2021	Form 3: Tango Therapeutics, Inc., Director · Blueprint Medicines Corp No securities owned
01 Nov 2021	Form 3: Rudoltz Marc, Chief Medical Officer No securities owned
01 Nov 2021	Form 3: Barry Douglas, See Remarks
20 Aug 2021	Form 3: Bctg Holdings, Llc, 10% owner Holds 6,988,450 shares of Common Stock
20 Aug 2021	Form 3: Boxer Capital, Llc, 10% owner and 3 others Holds 6,871,642 shares of Common Stock
12 Aug 2021	Form 3: Beckman Daniella, Chief Financial Officer Holds 63,867 shares of Common Stock
12 Aug 2021	Form 3: Weber Barbara, Director Holds 1,367,592 shares of Common Stock
12 Aug 2021	Form 3: Huber Reid M, Director No securities owned

Comments